KFDA to promote substitute dispensing of drugs
Published: 2003-07-21 06:59:00
Updated: 2003-07-21 06:59:00
The Korea Food and Drug Administration said it is pushing for a plan to increase the number of bioquivalence-exempted items which will be subject to drug equivalence without bioquivalence testing, as part of efforts to activate the substitute dispensing of drugs.
To that end, the KFDA has enc...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
